Patent Information

This web page serves as notice under 35 U.S.C. §287(a) that the following TriSalus product may be covered by one or more of the following US patents.

TriSalus’ patent portfolio includes the following issued U.S. patents:

TriSalus™ TriNav™ Infusion System

  • 10,588,636;
  • 10,780,250;
  • 10,813,739;
  • 11,090,460; and
  • 11,400,263.

 

 3

IMPORTANT NOTICE

You are now leaving the Trisalus life Sciences corporate website.

We encourage you to read and evaluate terms of use, privacy, security and other similar policies of the destination site as they may differ from TriSalus’ standards.

Third Party Sites

TriSalus assumes no responsibility nor does it control, endorse or guarantee any aspect of your use of any third party sites. Additionally, the presence of this link does not imply the third party site’s endorsement of TriSalus or this website.

Thank you for visiting our site.

CANCEL